The UMCG will make research facilities available for drug development

Area: Public Health

News

Area: Public Health

Published September 4, 2024

To improve the availability and effectiveness of medicines in the Netherlands, the UMCG is going tot set up the company G2 Solutions.

This company must ensure that important technological developments in the field of DNA sequencing and stem cell models become profitable so that they cn be further developed.

A subsidy of 5.7.million euros has been made available for this from the National Growth Fund.

Read the full article: The UMCG will make research facilities available for drug development (Dutch)

The UMCG will make research facilities available for drug development

Exploring and optimizing therapeutic strategies for borderline ovarian tumors and low-grade serous ovarian cancer

NWO Demonstrator grant for De Boer’s counter-intuitive treatment for cholestatic liver disease

Renal function in critically ill patients: assessment, replacement and histopathology

Footer navigatie

UMCG Research

Researchers

About UMCG

The UMCG will make research facilities available for drug development

Share

Other news

Exploring and optimizing therapeutic strategies for borderline ovarian tumors and low-grade serous ovarian cancer

NWO Demonstrator grant for De Boer’s counter-intuitive treatment for cholestatic liver disease

Renal function in critically ill patients: assessment, replacement and histopathology

UMCG Research

Researchers

About UMCG